Insider selling
Traded Nov 18 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −8.5% · S&P 500 −5.5% · to Nov 20
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
SMG · NYSE · Fertilizers & Agricultural Chemicals
Scotts Miracle-Gro Company (SMG) · oqro.io/stocks/SMG · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$58.60−2.78 (−4.53%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of Scotts Miracle-Gro Company was filed in the last 90 days. The latest on record was on Feb 25, 2026.
Since 2005, Scotts Miracle-Gro Company insiders reported 32 open-market purchases and 3,233 sales on Forms 4 and 5, with purchases in 11 different years, most recently 2026.
In the last 90 days, 2 insiders of Scotts Miracle-Gro Company (SMG) reported 2 open-market sales worth $416K in total on SEC Form 4. The largest seller by value was Peter E Shumlin, with $240K. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
No trade in Scotts Miracle-Gro Company (SMG) was disclosed by a member of Congress in the last 12 months.
Scotts Miracle-Gro Company's next results are expected on Jan 26, 2027. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+11.0% (+$5.81) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $52.79 on Nov 20, 2025 to $58.60 on Nov 20, 2026 (+11.0%). Disclosed in this range: 9 insider trades, 0 pre-arranged insider sales, 0 Congress trades, and 21 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Fertilizers & Agricultural Chemicals company based in Marysville, Ohio.
Last 12 months
+11.0%
Market value
$3.41B
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 5.16M shares sold short (8.9% of shares outstanding), −9.9% vs the previous count, 5.2 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Newer results were announced on Nov 4, 2026 and are not in these figures yet. Read the announcement.
Revenue
$1.17B
+1.1% vs the same quarter a year earlier
Free cash flow, last 12 months
$263M
This quarter $321M, a year earlier $438M
Net debt
$2.09B
Debt $2.11B, cash $27.7M, at Jun 27, 2026
Net income, last 12 months
$73.9M
Operating profit covers interest 3.38x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 4, 2026.
Revenue, fiscal 2025
$3.41B
−3.9% vs the year before
Net income, fiscal 2025
$145M
As reported in the annual filing
Shares outstanding
58.2M
As of Jul 31, 2026
In fiscal 2025 the company spent $18.4M buying back its own shares and $154M on dividends. Cash actually paid, from its cash-flow statement.
Last dividend: $0.66 a share (quarterly), ex-date Nov 20, 2026, payable Dec 4, 2026. Calendar
Insider selling
Traded Nov 18 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −8.5% · S&P 500 −5.5% · to Nov 20
A Scotts Miracle-Gro director sold $200K of Scotts Miracle-Gro shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 13 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade −8.2% · S&P 500 −8.6% · to Nov 20
A Scotts Miracle-Gro director sold $240K of Scotts Miracle-Gro shares. The filing does not indicate a pre-arranged trading plan.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Insiders of Scotts Miracle-Gro Company reported 32 open-market purchases and 3,233 sales since 2005; purchases in 11 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $50K1×1 trade | $5.89M7×7 trades |
| 2025 | $110K1×1 trade | $24.9M16×16 trades |
| 2024 | — | $42.2M30×30 trades |
| 2023 | — | $27M26×26 trades |
| 2022 | — | $35.1M26×26 trades |
| 2021 | $1.03M3×3 trades | $69M89×89 trades |
| 2020 | — | $136M167×167 trades |
| 2019 | — | $144M93×93 trades |
| 2018 | $600K1×1 trade | $36.3M32×32 trades |
| 2017 | — | $35M33×33 trades |
| 2016 | — | $28.1M24×24 trades |
| 2015 | — | $37.3M51×51 trades |
| 2014 | $46K1×1 trade | $75.8M533×533 trades |
| 2013 | $105K3×3 trades | $176M587×587 trades |
| 2012 | — | $93.4M350×350 trades |
| 2011 | $159K17×17 trades | $110M171×171 trades |
| 2010 | $506K2×2 trades | $63.3M255×255 trades |
| 2009 | $25K1×1 trade | $40.3M291×291 trades |
| 2008 | — | $8.11M168×168 trades |
| 2007 | $84K1×1 trade | $16M131×131 trades |
| 2006 | — | $37.1M135×135 trades |
| 2005 | $16K1×1 trade | $1.13M18×18 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Last results
Nov 4, 2026
Within the 30 days after it, until Dec 4, 2026
Next results, expected
Jan 26, 2027
Purchases after results
Not enough history
From Scotts Miracle-Gro Company's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Scotts Miracle-Gro Company's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
3 certified in FY2026 Q3, vs 6 a year earlier. 3 positions in total, median offered wage $102K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
A securities lawsuit naming the company as a defendant was filed on Nov 19, 2024 in the U.S. District Court, S.D. Ohio. A filing is an allegation, not a finding.
Carone v. The Scotts Miracle-Gro Company, 2:24-cv-04180A securities lawsuit naming the company as a defendant was filed on Jul 26, 2024 in the U.S. District Court, S.D. Ohio. A filing is an allegation, not a finding.
City of Inkster Policemen and Firemen Retirement System v. Scotts Miracle-Gro Company, 2:24-cv-03766A securities lawsuit naming the company as a defendant was filed on Jun 6, 2024 in the U.S. District Court, S.D. Ohio. A filing is an allegation, not a finding.
In re The Scotts Miracle-Gro Company Securities Litigation, 2:24-cv-03132Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). Coverage of court records is not complete, and shareholder derivative suits are not included.
Fiscal year Oct 1, 2024 to Sep 30, 2025, from the annual report filed Nov 25, 2025. Read the filing
−0.7% on the year before ($3.01B)
+3.8% on the year before ($244M)
−44% on the year before ($295M)
The company also reports Reportable segment total ($3.16B), which group lines above and are not added again.
−3.5% on the year before ($3.25B)
−8.6% on the year before ($305M)
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 12,000 words.
U.S. Consumer consists of our consumer lawn and garden business in the United States. Hawthorne consists of our indoor and hydroponic gardening business. Other primarily consists of our consumer lawn and garden business in Canada. Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the operating segments. See “SEGMENT RESULTS” below for additional information regarding our evaluation of segment performance. Through our U.S. Consumer and Other segments, we are the leading marketer of branded consumer lawn and garden products in North America. Our products are marketed under some of the most recognized brand names in the industry.
Source: SEC EDGAR, Form 10-K filed Nov 25, 2025. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
And 26 more headings in the filing.
Fails to deliver: 47K shares (about $2.57M) were not delivered on time for settlement on Oct 19, 2026. SEC fails-to-deliver data.
Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 44.5% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (34.0% on ATS, 10.5% with other brokers), close to its 26-week average of 43.6%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: INTELLIGENT CROSS LLC (13.7%), UBS ATS (11.2%), LEVEL ATS (10.7%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Against the S&P 500 over the year
Since Nov 19, 2025, SMG is up 10.0% and the index fund is up 4.1%: 6 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much SMG moves
Beta 0.7 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
Latest annual report filed Nov 25, 2025, compared with the one filed Nov 26, 2024. Read the filing
As noted in the discussion in “ITEM 1. BUSINESS — Regulatory Considerations — Regulatory Matters” of this Form 10-K, we are involved in several pending environmental and regulatory matters. We believe that our assessment of contingencies is reasonable and that the related accruals, in the aggregate, are adequate; however, there can be no assurance that the final resolution of these matters will not have a material effect on our financial condition, results of operations or cash flows.
Source: SEC EDGAR, Form 10-K filed Nov 25, 2025. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.